Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DX25F6RQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,723
Award facts
- Contract value 100% obligated
- $24,723.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes with a firm fixed price ceiling value of $24,723.24 and an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract was executed on July 14, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other inflammatory conditions, making this a specialized pharmaceutical procurement supporting military healthcare requirements.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6RQW?
SPE2DX25F6RQW was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2DX25F6RQW worth?
The government has obligated $24,723 on SPE2DX25F6RQW.
Is contract SPE2DX25F6RQW an order under another contract?
Yes. SPE2DX25F6RQW is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6RQW competed?
The extent of competition for SPE2DX25F6RQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award